GlassScriptPhysician profile
Kelly White
NPI 1457718975
$989.94
in general payments reported to CMS, 2019-2025
24 companies · $236 in 2025
The $236 reported for 2025 was more than what 79% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.11 · 2023: $248 · 2024: $483 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $116.26 | 2023 | Xpovio |
| Novo Nordisk INC | $96.38 | 2024-2025 | Wegovy |
| Abbvie INC. | $78.64 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $66.48 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $65.63 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $62.78 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.44 | 2024-2025 | |
| Dynavax Technologies Corporation | $59.03 | 2024 | Heplisav-B |
| Lilly USA, LLC | $49.68 | 2024-2025 | Jardiance |
| Ironshore Pharmaceuticals INC. | $46.03 | 2023-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $33.19 | 2024-2025 | Vaxneuvance, Proquad, Rotateq |
| Phathom Pharmaceuticals, INC. | $31.50 | 2024 | Voquezna |
| Beigene USA, INC. | $23.11 | 2021 | |
| Sanofi Pasteur INC. | $21.81 | 2023 | |
| Viiv Healthcare Company | $20.52 | 2024 | Apretude |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20.12 | 2025 | Intellis Adaptivestim |
| Neos Therapeutics, LP | $19.84 | 2025 | Adzenys Xr-Odt |
| Corium, LLC | $19.68 | 2023 | Azstarys |
| Tempus Ai, INC | $19.59 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.28 | 2024 | Jardiance |
| Hologic Sales and Service, LLC | $17.14 | 2024 | Aptima |
| Gilead Sciences, INC. | $16.12 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.53 | 2024 | Xifaxan |
| Cranial Technologies, INC | $14.16 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.